The role of tumoral dihydropyrimidine dehydrogenase activity
Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors.
Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape.
Selective targeting of tumoral vasculature: comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin.
An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy.
Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganci...
Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis
Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T cell function to promote tumoral immune escape
Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity
CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V g...
